FI113540B - Menetelmä terapeuttisesti käyttökelpoisten biskonjugaattien valmistamiseksi, jotka sisältävät kaksi sakkaridia ja spacer-osan - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten biskonjugaattien valmistamiseksi, jotka sisältävät kaksi sakkaridia ja spacer-osan Download PDF

Info

Publication number
FI113540B
FI113540B FI944001A FI944001A FI113540B FI 113540 B FI113540 B FI 113540B FI 944001 A FI944001 A FI 944001A FI 944001 A FI944001 A FI 944001A FI 113540 B FI113540 B FI 113540B
Authority
FI
Finland
Prior art keywords
spacer
saccharide
compound
oso3
bisconjugate
Prior art date
Application number
FI944001A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI944001A0 (fi
FI944001A (fi
Inventor
Boeckel Constant Adriaan A Van
Peter Diederik Jan Grootenhuis
Maurice Petitou
Pieter Westerduin
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of FI944001A0 publication Critical patent/FI944001A0/fi
Publication of FI944001A publication Critical patent/FI944001A/fi
Application granted granted Critical
Publication of FI113540B publication Critical patent/FI113540B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI944001A 1993-09-01 1994-08-31 Menetelmä terapeuttisesti käyttökelpoisten biskonjugaattien valmistamiseksi, jotka sisältävät kaksi sakkaridia ja spacer-osan FI113540B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93202562 1993-09-01
EP93202562 1993-09-01

Publications (3)

Publication Number Publication Date
FI944001A0 FI944001A0 (fi) 1994-08-31
FI944001A FI944001A (fi) 1995-03-02
FI113540B true FI113540B (fi) 2004-05-14

Family

ID=8214074

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944001A FI113540B (fi) 1993-09-01 1994-08-31 Menetelmä terapeuttisesti käyttökelpoisten biskonjugaattien valmistamiseksi, jotka sisältävät kaksi sakkaridia ja spacer-osan

Country Status (20)

Country Link
US (1) US5705489A (zh)
EP (1) EP0649854B1 (zh)
JP (1) JP3918953B2 (zh)
KR (1) KR100365578B1 (zh)
AT (1) ATE190619T1 (zh)
AU (1) AU679084B2 (zh)
BR (1) BR1100612A (zh)
CA (1) CA2131229C (zh)
DE (1) DE69423414T2 (zh)
DK (1) DK0649854T3 (zh)
ES (1) ES2147216T3 (zh)
FI (1) FI113540B (zh)
GR (1) GR3033410T3 (zh)
HK (1) HK1002009A1 (zh)
HU (1) HU227279B1 (zh)
NO (1) NO301984B1 (zh)
NZ (1) NZ264340A (zh)
PT (1) PT649854E (zh)
TW (1) TW349951B (zh)
ZA (1) ZA946673B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9201440A (nl) * 1992-08-11 1994-03-01 Univ Leiden Triantennaire clusterglycosiden, hun bereiding en toepassing.
DE19624705A1 (de) * 1996-06-20 1998-01-08 Deutsches Krebsforsch Dendrimere auf Saccharid-Basis
FR2751334B1 (fr) 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773801B1 (fr) * 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
US6486129B1 (en) * 1998-06-17 2002-11-26 Akzo Nobel N.V. Antithrombotic compounds
WO2001012675A1 (fr) * 1999-08-10 2001-02-22 Seikagaku Corporation Derives de glycosaminoglycane et leur utilisation
TWI289566B (en) * 1999-12-07 2007-11-11 N.V.Organon Antithrombotic compound
DE10041221A1 (de) * 2000-08-22 2002-03-14 Deutsches Krebsforsch Verfahren zur Herstellung von wasserlöslichen Saccharidkonjugaten und Saccharidmimetika durch Diels-Alder-Reaktion und ihre Verwendung als Therapeutika oder Diagnostika
EP1574516A1 (en) 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound
FR2874924B1 (fr) 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
EP1886696A1 (en) * 2006-08-03 2008-02-13 Endotis Pharma Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins
EP2421878B1 (en) * 2008-10-03 2017-06-14 Glycan Biosciences LLC Anionic oligosaccharide conjugates
FR2949115B1 (fr) 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949114B1 (fr) 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
WO2012042123A1 (fr) 2010-09-10 2012-04-05 Sanofi Polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree
FR2970969B1 (fr) 2011-01-27 2013-10-18 Sanofi Aventis Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique
EP2578594A1 (en) * 2011-10-04 2013-04-10 Sanofi Process of preparation of L-iduronic acid comprising a decarboxylation/intramolecular cyclisation tandem reaction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818816A (en) * 1981-04-28 1989-04-04 Choay, S.A. Process for the organic synthesis of oligosaccharides and derivatives thereof
DE3734815A1 (de) * 1987-10-14 1989-04-27 Luitpold Werk Chem Pharm Polyschwefelsaeureester von bis-aldonsaeureamiden und deren derivaten, verfahren zu ihrer herstellung und arzneimittel
DE3734853A1 (de) * 1987-10-14 1989-04-27 Luitpold Werk Chem Pharm Bis-aldonsaeureamide und verfahren zu ihrer herstellung
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
EP0347964A1 (en) * 1988-06-21 1989-12-27 Akzo N.V. New oligosaccharides with internal spacer
DE69100275T2 (de) * 1990-04-23 1993-12-02 Akzo Nv Eine Trisaccharideinheit enthaltende Kohlenhydratderivate.

Also Published As

Publication number Publication date
CA2131229A1 (en) 1995-03-02
KR100365578B1 (ko) 2003-03-19
HUT69163A (en) 1995-08-28
BR1100612A (pt) 2003-02-25
KR950008528A (ko) 1995-04-19
HK1002009A1 (en) 1998-07-24
GR3033410T3 (en) 2000-09-29
FI944001A0 (fi) 1994-08-31
ATE190619T1 (de) 2000-04-15
JPH07304787A (ja) 1995-11-21
EP0649854A1 (en) 1995-04-26
DK0649854T3 (da) 2000-07-03
ES2147216T3 (es) 2000-09-01
CA2131229C (en) 2005-04-12
NZ264340A (en) 1995-04-27
TW349951B (en) 1999-01-11
ZA946673B (en) 1995-04-21
FI944001A (fi) 1995-03-02
NO943222L (no) 1995-03-02
NO301984B1 (no) 1998-01-05
HU9402514D0 (en) 1994-10-28
AU7161094A (en) 1995-03-16
PT649854E (pt) 2000-07-31
DE69423414D1 (de) 2000-04-20
AU679084B2 (en) 1997-06-19
DE69423414T2 (de) 2000-09-21
HU227279B1 (en) 2011-01-28
US5705489A (en) 1998-01-06
NO943222D0 (no) 1994-08-31
EP0649854B1 (en) 2000-03-15
JP3918953B2 (ja) 2007-05-23

Similar Documents

Publication Publication Date Title
FI113540B (fi) Menetelmä terapeuttisesti käyttökelpoisten biskonjugaattien valmistamiseksi, jotka sisältävät kaksi sakkaridia ja spacer-osan
FI90242C (fi) Menetelmä terapeuttisesti käyttökelpoisen pentasakkaridin valmistamiseksi
KR0185991B1 (ko) 3당류 유니트를 함유하는 탄수화물 유도체
FR2535324A1 (fr) Station perfectionnee pour l'epuration d'eaux usees
Unverzagt et al. Stereoselective synthesis of glycosides and anomeric azides of glucosamine
NO179452B (no) Sulfaterte glukosamin-glukanoid-derivater
US3243425A (en) Novel sulfur-containing compounds
SI9620099A (sl) Diglikozilirani 1,2-dioli kot mimetiki sialil-Lewis X in sialil-Lewis A
Hecker et al. Synthesis of compounds designed to inhibit bacterial cell wall transglycosylation
HU226685B1 (en) Carbohydrate derivatives and pharmaceutical compns. contg. them
AU4512999A (en) Antithrombotic compounds
FI101796B (fi) Uusia -glukosidaasi-inhibiittoreita
AU2010234779A1 (en) Heparan sulfate synthesis
CA1269367A (en) Sialosylcerebrosides and a preparation method thereof
EP0024727A1 (en) Anthracycline glycosides, processes for their preparation and pharmaceutical composition containing them
Sztaricskai et al. A Synthesis of L-Ristosamine and a Derivative of its C-4 Epimer
Tamura et al. Effect of Protecting Groups and Solvents in Anomeric O-Alkylation of Mannopyranose1
EP0424899A2 (en) Novel anthracycline glycoside derivatives and preparing method thereof
RU2065863C1 (ru) Производные дезацетилколхицина, способ их получения и противоопухолевая композиция
EP0479175B1 (en) Pradimicin derivatives
Tamura et al. Synthetic Studies of Glycosyl Serines in the Carbohydrate‐Protein Region of Protoglycans
Wong et al. The synthesis of derivatives of lactosamine and cellobiosamine to serve as probes in studies of the combining site of the monoclonal anti-I Ma antibody
Bär et al. Synthesis of β‐lactosyl 1‐thioceramide
Kornhauser et al. Glycosyl esters of amino acids: Part I. Synthesis of 1-O-(2-acetamidoacyl)-2, 3, 4, 6-tetra-O-acetyl-β-d-glucopyranoses
EP3231810A1 (en) Improved preparation of vaccines against streptococcus pneumoniae type 3

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: SANOFI-AVENTIS

MA Patent expired